Brown R C, Silver A C, Woodhead J S
Department of Medical Biochemistry, University of Wales College of Medicine, Cardiff, United Kingdom.
Am J Physiol. 1991 Apr;260(4 Pt 1):E544-52. doi: 10.1152/ajpendo.1991.260.4.E544.
The binding and cellular processing of NH2-terminal parathyroid (PTH) hormone by confluent monolayers of opossum kidney (OK) cells was characterized using radiolabeled PTH peptide analogues. Time- and temperature-dependent specific binding of 125I-labeled (Nle-8,18, Tyr-34)-NH2-bovine(b)PTH-(1-34) was accompanied by the appearance of degraded radiolabel in the cell medium. Degrading activity was observed to be a specific consequence of binding by PTH receptors. Degrading activity was inhibited by monensin, chloroquine, and NH4+ but not by chymotrypsin inhibitors. Acid washing demonstrated that greater than 80% of total cell-associated specific binding at equilibrium was located in a rapidly internalized (acid-resistant) pool. Monensin pretreatment led to increased acid-resistant binding, presumably through inhibition of turnover of internalized receptor ligand and indicated that the degradation of radiolabel was probably associated with processing of the receptor-ligand complex. Release of intact radiolabel from the acid-resistant pool indicated that some of the internalized peptide was recycled out of the cell in an undegraded form (retroendocytosis). Acid-resistant binding and degradation of 125I-(Nle-8,18, Tyr-34)-NH2-bPTH-(3-34) was minimal, indicating that this ligand was not internalized. It is concluded that the binding and internalization of PTH-(1-34) fragment by confluent OK cells is a specific receptor-mediated process. Cellular processing of PTH-(1-34) conforms to established models of internalization by receptor-mediated endocytosis.
利用放射性标记的甲状旁腺激素(PTH)肽类似物,对负鼠肾(OK)细胞融合单层对氨基末端甲状旁腺(PTH)激素的结合及细胞处理过程进行了表征。125I标记的(Nle-8,18,Tyr-34)-氨基末端牛(b)PTH-(1-34)的时间和温度依赖性特异性结合伴随着细胞培养基中降解放射性标记物的出现。观察到降解活性是PTH受体结合的特定结果。莫能菌素、氯喹和NH4+可抑制降解活性,但胰凝乳蛋白酶抑制剂则不能。酸洗表明,平衡时细胞相关特异性结合总量的80%以上位于快速内化(耐酸)池中。莫能菌素预处理导致耐酸结合增加,推测是通过抑制内化受体配体的周转,这表明放射性标记物的降解可能与受体-配体复合物的处理有关。从耐酸池中释放完整的放射性标记物表明,一些内化的肽以未降解的形式从细胞中循环出来(逆向胞吞作用)。125I-(Nle-8,18,Tyr-34)-NH2-bPTH-(3-34)的耐酸结合和降解极少,表明该配体未被内化。结论是,融合的OK细胞对PTH-(1-34)片段的结合和内化是一个特定的受体介导过程。PTH-(1-34)的细胞处理符合受体介导的内吞作用的既定内化模型。